Cochrane Abstracts
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Diabetic Macular Oedema: a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433924/all/Anti‐vascular_endothelial_growth_factor_for_diabetic_macular_oedema:_a_network_meta‐analysis.
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433924/all/Anti‐vascular_endothelial_growth_factor_for_diabetic_macular_oedema:_a_network_meta‐analysis. Accessed January 22, 2025.
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433924/all/Anti‐vascular_endothelial_growth_factor_for_diabetic_macular_oedema:_a_network_meta‐analysis
Anti‐vascular Endothelial Growth Factor for Diabetic Macular Oedema: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433924/all/Anti‐vascular_endothelial_growth_factor_for_diabetic_macular_oedema:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
ID - 433924
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433924/all/Anti‐vascular_endothelial_growth_factor_for_diabetic_macular_oedema:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
